BioCorRx Inc. (OTCMKTS:BICX – Get Free Report)’s share price traded down 23% during mid-day trading on Monday . The stock traded as low as $0.35 and last traded at $0.39. 1,804 shares were traded during mid-day trading, a decline of 14% from the average session volume of 2,108 shares. The stock had previously closed at $0.50.
BioCorRx Price Performance
The firm’s 50-day moving average price is $0.34 and its 200-day moving average price is $0.40. The company has a market cap of $5.00 million, a price-to-earnings ratio of -0.74 and a beta of 0.60.
BioCorRx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
See Also
- Five stocks we like better than BioCorRx
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- 3 Healthcare Dividend Stocks to Buy
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Investing in Travel Stocks Benefits
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
